Disease: Colon Polyps

    Colon polyp facts

    • Colon polyps are growths on the inner lining of the colon and are very common.
    • Colon polyps are important because they may be, or may become malignant (cancerous). They also are important because based on their size, number, and histology, they can predict which patients are more likely to develop further polyps and colon cancer.
    • Changes in the genetic material of cells lining the colon are the cause of polyp formation.
    • There are different types of colon polyps with differing tendencies to become malignant and abilities to predict the development of more polyps and cancer. It is important to recognize families with members who have familial genetic conditions causing polyps because some of these conditions are associated with a very high incidence of colon cancer.
    • Only a small proportion of polyps cause symptoms or signs. When they do, the symptoms and signs usually are the result of bleeding from the polyp.
    • Colon polyps are diagnosed by endoscopic colonoscopy, virtual colonoscopy, barium enema, and flexible sigmoidoscopy.
    • Colon polyps are treated by endoscopic removal and occasionally by surgery.
    • Follow-up surveillance of patients with colon polyps depends on the presence of a family history of cancer, the number of polyps that are found, the size of the polyps, and the polyps' histology, and can vary between three and ten years.
    • Treatments to prevent colon polyps are being pursued actively.

    What are colon polyps?

    Colon polyps are growths that occur on the inner lining of the large intestine (colon) and protrude into the colon. They can vary in size from a few millimeters to several centimeters. Polyps form when the genetic material within cells lining the colon changes and becomes abnormal (mutates). Normally, the immature cells lining the colon are programmed to divide (multiply), mature, and then die in a very consistent and timely fashion. However, the genetic changes that occur in the lining cells prevents the cells from maturing, and the cells do not die. This leads to an accumulation of immature, genetically abnormal cells, which eventually results in the formation of polyps. The mutations may occur as a sporadic event after birth or they may be present from before birth.

    Picture of colon (colorectal) cancer.

    How common are colon polyps?

    Colon polyps are very common. They increase in prevalence as people age; by age 60, one-third or more people will have at least one polyp. If a person has a colon polyp, he or she is more likely to have additional polyps elsewhere in the colon and is more likely to form new polyps at a later time. In a small subset of patients with colon polyps, there is a familial, genetic abnormality that causes them and other members of their families to develop larger numbers of polyps, to develop them at an early age, and to more frequently have them become cancerous (malignant).

    Why are colon polyps important?

    Colon polyps are important because they may give rise to colon cancer. Depending on the type of polyp, they predict who is more likely to develop further polyps and colon cancer. Polyps cause other problems (to be discussed), but it is the deadly nature of colon cancer that is of most concern.

    Benign polyps become malignant polyps (cancer) with further mutations and changes in the cells' genetic material (genes). The cells begin to divide and reproduce uncontrollably, sometimes giving rise to a larger polyp. Initially, the increasingly, genetically abnormal cells are limited to the layer of cells that line the inside of the colon. The cells then then develop the ability to invade deeper into the wall of the colon. Individual cells also develop the ability to break off from the polyp and spread into lymph channels through the wall of the colon to the local lymph nodes and then throughout the body, a process referred to as metastasis.

    The transition from benign to malignant polyp can be seen under the microscope. In the earlier phase of the transition, called low-grade dysplasia (dysplasia=abnormal formation), the cells and their relationships to one another become abnormal. When the cells and their relationships become even more abnormal, it is termed high-grade dysplasia. High-grade dysplasia is of greater concern because the cells are clearly cancerous although they are limited to the innermost lining of the colon; with rare exceptions, they have not yet developed the abilities to invade and metastasize. If they are not removed, invasion and metastasis may occur.

    Are all colon polyps the same?

    No, all polyps are not the same. There are different histologic types, that is, the cells that make up the polyp have different characteristics when viewed under the microscope. They also vary in size, number, and location. Most importantly, they vary in their tendency to become cancerous (malignant).

    Adenomatous polyps

    The most common type of polyp is the adenoma or adenomatous polyp. It is an important type of polyp not only because it is the most common, but because it is the most common cause of colon cancer. The likelihood that an adenoma will develop into (or has already developed into) cancer is partially dependent on its size; the larger the polyp, the more likely it is that the polyp is or will become malignant. Concern about the malignant potential increases with a polyp the size greater than one centimeter. It also matters if there is a single polyp or multiple polyps. Patients with multiple polyps - even if they are not malignant when examined under the microscope--are more likely to develop additional polyps in the future that may become malignant. Concern about this increasing malignant potential begins when there are three or more polyps. Finally, the malignant potential of an adenomatous polyp is related to the manner in which the cells of the polyp organize themselves as seen under the microscope. Cells that organize themselves into tubular structures (tubular adenomas) are less likely to become cancerous than cells that organize themselves into finger-like structures (villous adenomas).

    Most adenomatous polyps are considered sporadic, that is, they do not stem from a recognized genetic mutation that is present at birth. Nevertheless, the risk of having colon polyps greater than one centimeter in size or developing colon cancer is two-fold greater if a first degree relative has colon polyps greater than one centimeter in size. Therefore, there it is likely to be a genetic factor working even in sporadic adenomatous polyps.

    Genetic adenomatous polyp syndromes

    There are several familial, genetic conditions in which the mutations or the development of mutations are programmed into an individual's genes from before birth, passed down from parent to child. In the most common of these conditions, hundreds to thousands of adenomatous polyps form (familial adenomatous polyposis or FAP) as a result of a mutation in the APC gene. It is important to recognize these polyposis syndromes and the exact genetic abnormality that causes them, if possible since the malignant potential of these polyps is much greater than that of individuals without the genetic abnormality. (Eighty percent or more of these patients develop colon cancer.) Even though these syndromes are responsible for only a few percent of all colon cancers, recognition of a polyposis syndrome identifies patients in whom screening for additional polyps needs to be done more frequently so that new polyps and cancers can be discovered and treated early. It may even be recommended that the entire colon be removed to prevent cancer. In addition, genetic testing can be done for relatives of the patient with polyps to determine whether or not the relative has the same mutation as the patient and, therefore, is very likely to develop polyps and cancer. Relatives with the same mutation then can be screened for the presence of polyps and cancer, preferably starting at an earlier age than would normally be done because cancers in these syndromes develop at an earlier age than cancers not associated with a syndrome. Because of the autosomal dominant mode of transmission of the gene and its effects, only one parent needs to have the FAP gene to pass on to his or her children, and there is a 50/50 chance that each of his or her children will have FAP.

    There is an uncommon form of FAP in which the number of polyps is less than classic FAP - less than 100--called attenuated FAP. The mutation in the APC gene in attenuated FAP is different than the mutation in classic FAP. Patients with many polyps but not the numbers seen in FAP should be identified and tested for the mutation. Unlike FAP which is an autosomal dominant syndrome, attenuated FAP is a recessive mutation so that an individual needs to inherit one mutated gene from each parent to develop polyps and colon cancer, and because of the rarity of the mutation, this occurs rarely.

    Another syndrome of polyps and colon cancer is the MYH polyposis syndrome. Individuals with MYH polyposis develop less than 100 polyps at a young age and are at high risk for developing colon cancer. It is caused by mutations in a different gene than FAP, the MYH gene; however, the mutation occurs sporadically due to spontaneous mutations and, therefore, a hereditary pattern is not apparent in parents, but may be seen in siblings. Because it is an autosomal recessive gene that requires a mutated gene from each parent, the MYH polyposis syndrome is rare.

    Genetic adenomatous polyp syndromes

    The second most common type of colon polyp is the hyperplastic polyp. It is important to recognize these polyps and to differentiate them from adenomatous polyps since they have little or no potential to become cancerous unless they are located in the proximal (ascending colon), or show a particular histologic pattern under the microscope (a serrated appearance). Nevertheless, there are uncommon genetic syndromes in which patients form many hyperplastic polyps. These patients may be at a similar risk for developing colon cancer as patients with multiple adenomatous polyps, particularly if the polyps are large, serrated, located in the ascending colon, and there is a family history of colon cancer. Hyperplastic polyps may coexist with adenomatous polyps.

    Other types of colon polyps

    Much less common types of colon polyps exist, and their potential for becoming cancerous varies greatly, for example, hamartomatous, juvenile, and inflammatory polyps.

    What are the symptoms and signs of colon polyps?

    Ninety-five percent of colon polyps do not cause any symptoms or signs. The most common symptoms or signs when they do occur are those of bleeding from the polyp. This usually results in small amounts of blood in the stool, enough to turn stool tests for occult (hidden) blood abnormal, but not enough to change the color of stool. Occasionally when bleeding is substantial, the stool may become black, maroon or bright red.

    More commonly, however, the bleeding continues at a slow pace and can result in anemia due to a loss and subsequent deficiency of iron. If this happens, symptoms of anemia - weakness, light-headedness or fainting especially upon standing, pale skin, rapid heart rate, and occasionally congestive heart failure, stroke, or heart attack - may occur.

    (The reason that colon cancer screening often involves stool tests for occult blood is that colon polyps have a tendency to bleed; screening for blood in the stool identifies patients with a higher likelihood of having colon polyps who need colonoscopy to look for and remove the polyps.)

    How are colon polyps diagnosed?

    There are several means to diagnose colon polyps.

    Endoscopic colonoscopy

    Endoscopic colonoscopy involves the use of a colonoscope, a flexible tube approximately five feet in length with a light and camera at the end and a hollow channel through which instruments can be passed. The colonoscope is passed via the anus into the colon and then through the colon until the proximal end of the colon - the cecum - is reached. On withdrawal of the colonoscope, the lining of the colon is observed for polyps and other abnormalities. These may be biopsied or removed using electro-cautery and then examined under the microscope. Colonoscopy identifies 95% of polyps, small and large, though occasionally polyps are missed if they are small, hidden by folds in the colon's lining, or the colonoscopy is hurried.

    Virtual colonoscopy

    Virtual colonoscopy involves the use of either computerized tomography (CT) or magnetic resonance imaging (MRI). The colon is filled with either a liquid contrast agent or air, and CT or MRI is performed. Computerized reconstruction of either the CT or MRI images provides a virtual image that mimics the view obtained by a colonoscope. Virtual colonoscopy is very good at finding polyps but not as good as colonoscopy; it can miss polyps less than one centimeter in size, although the need to identify these smaller polyps is debated since they infrequently are malignant. MRI has an advantage over CT because of it does not expose the patient to radiation. It is more expensive, however, and there is less experience with MRI than with CT. The problem with both CT and MRI virtual colonoscopy is that if a polyp is found that should be removed, colonoscopy then must be done at a later time to remove it.

    Barium enema

    Barium enema is an older method of diagnosing colon polyps. During a barium enema, the colon is filled with barium, and multiple X-rays of the colon are taken as the patient changes position. Barium enema is a good way to diagnose polyps and is relatively inexpensive; however, it can easily miss small polyps and exposes patients to radiation. Moreover, the skills and experience necessary to do a barium enema properly have declined among radiologists because barium enemas are less frequently ordered now that colonoscopy and virtual colonoscopy are available. Finally, like virtual colonoscopy, if polyps are found, a colonoscopy must be done to remove the polyp.

    Flexible sigmoidoscopy

    Flexible sigmoidoscopy uses a shortened version of a colonoscope, approximately three feet in length. It is able to examine only the distal third to one-half of the colon. Like the colonoscope, it can be used to identify, biopsy, and remove polyps without exposure to radiation. For screening purposes, since the sigmoidoscope cannot examine the entire colon, it usually is combined with either less frequent colonoscopy or frequent stool occult blood tests to identify polyps beyond its reach.

    How are colon polyps treated?

    Most polyps can be removed through the endoscope. They are then examined under the microscope. It is important to determine whether or not they contain cancer, if they are of a type that has malignant potential, and if they have characteristics that make them more likely to be associated with cancer, either in another polyp at the same time or in polyps that may form in the future (for example, are villous or serrated).

    The results of the colonoscopy and histologic examination are important because they determine the need for increased frequency of screening colonoscopy in the future (for example, adenomatous polyps). If there is cancer already present in the polyp it is important to determine how deep into the polyp the cancer has spread. If it extends deeply, it is more likely that the cancer has spread deep into the wall of the colon or even to lymph nodes further away. If there is deep extension of the cancer, it may be necessary to do additional endoscopic resection of the area of colon where the polyp was or, to surgically remove the section of colon, in order to be certain that all of the cancer has been removed.

    If a genetic mutation is suspected, it is looked for by genetic testing on a portion of the biopsy, and, if present, relatives should be screened for the same mutation. If present, the relatives should undergo more frequent screening colonoscopy.

    It is recommended that patients with FAP and other polyp syndromes have their colon removed prophylactically to prevent the development of cancer.

    How is screening for colon polyps done?

    Screening for colon polyps - as well as colon cancer - may use single or multiple diagnostic modalities including fecal occult blood testing, colonoscopy, virtual colonoscopy, and sigmoidoscopy. The frequency of screening varies depending on the risk of new polyps or cancers occurring.

    How should patients with colon polyps be followed?

    Several expert groups have made recommendations for surveillance in individuals who have been found to have polyps on their initial examination, which usually is endoscopic colonoscopy but occasionally virtual colonoscopy or flexible sigmoidoscopy. The recommendations vary slightly from group to group but not in important ways. They all make recommendations on the basis of factors such as family history of polyps and colon cancer, the number of polyps that are found, the size of the polyps, and the polyps' histology. By using these factors, the interval between surveillance procedures can be tailored to the risk of developing further polyps and malignancy in the future - the higher the risk, the shorter the interval between surveillance procedures. The recommendations that follow are modified from the guidelines proposed by the U.S. Multi-Society Task Force on Colorectal Cancer published in 2012.

    Second examination
    • If no polyps are found on the first examination it is recommended that a second examination should be done 10 years later.
    • If the only polyps that are found are hyperplastic polyps, and they are limited to the rectum and sigmoid colon and they are all less than one centimeter in size, a second examination is recommended in 10 years.
    • If one or two tubular adenomas are found and they are less than one centimeter in size, a second examination is recommended in five years though a longer interval may be reasonable as well.
    • If three to ten adenomas are found, it is recommended that a second examination be done in three years.
    • If more than ten adenomas are found, it is recommended that a second examination be done in three years or less.
    • If one or more tubular adenomas are found that are greater than one centimeter in size, a second examination is recommended in three years.
    • If one or more adenomas are found of any size and their histology is villous, a second examination is recommended in three years.
    • If one or more adenomas are found and any show high grade dysplasia, a second examination is recommended in three years.
    • If serrated polyps are found, recommendations are less secure because much less information is available about the future risk of polyps and cancers. Concerns are greater (and the interval to the next examination should be shorter) if the polyps are proximal (in the ascending colon), are larger (more than one centimeter in size), and particularly if they show dysplasia.
    Additional examinations

    Adenomas can be classified as low risk (LRA) and high risk (HRA) for cancer.

    LRA is defined as one to two tubular adenomas less than one centimeter in size.

    HRA is defined as three or more adenomas, with one tubular adenoma greater than one centimeter in size, or an adenoma with villous histology or high-grade dysplasia.

    Recommendations regarding when to have the third and subsequent examinations depend on the presence of LRA or HRA on the first and second examinations and can vary between three and 10 years.

    Are all colon cancers associated with polyps?

    No, although most colon cancers arise from polyps, some do not. Some arise within the wall of the colon. These cancers may be flat or even depressed (excavated). They are more difficult to identify and treat, and they are more likely to spread into the wall of the colon and nearby lymph nodes than cancers originating in polyps. This is particularly true of serrated adenomatous polyps which usually are flat rather than polypoid in appearance.

    There also is a familial, genetic syndrome called hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) in which colon cancers occur with very high incidence (80% or more of patients). There are few or no polyps to identify in these patients. Moreover, the cancers occur at a younger age, often prior to the time screening for colon cancer is recommended to begin, and the syndrome is not recognized until a family member develops cancer usually at a young age. HNPCC is suspected because other family members also have colon cancer and certain criteria are met (Amsterdam or Bethesda criteria), or the cancer shows a particular pattern under the microscope with special stains. If HNPCC is suspected, genetic testing on the cancer can be done to identify the hereditary mutation, and other family members can be tested for the same mutation. If present, the family members can begin screening colonoscopies. HNPCC may be associated with cancers in tissues outside the colon as well. Fortunately, HNPCC is responsible for only a few percent of all colon cancers.

    Can colon polyps be prevented?

    Because of concern regarding the transition of polyps to cancer, attempts have been made to determine if treatments with theoretical potential actually prevent polyps. The problem with most studies is that they are retrospective, observational studies which are not sufficient as proof. The long period of time (many years) that it takes for polyps to form makes long term studies mandatory, but such studies have been difficult to do except in the case of familial, genetic polyposis syndromes, and, because of the differences in their causes, it is not clear if what applies to them applies to the more common sporadic adenomas.

    Several associations have been explored for antioxidants including selenium, beta carotene, and vitamins A, C, and E. Most of the studies that have been done do not support a role for these agents in preventing polyps or in preventing colon cancer. A limited amount of support is available for the use of selenium to prevent polyps, but selenium is not recommended for use outside of experimental trials.

    Supplemental dietary calcium has been demonstrated in one study to prevent the formation of polyps. The benefit was seen with supplementation of 1200 mg of calcium. There is some concern about using calcium since higher dietary and supplemental levels are associated with an increase in vascular disease. The intake of calcium that was studied was higher than the recommended intake of calcium, 800 mg.

    The best support for a treatment to prevent polyps is with nonsteroidal anti-inflammatory drugs (NSAIDs), a class of drugs that includes aspirin, ibuprofen (Motrin, Advil), celecoxib (Celebrex), and many others. Aspirin has been shown in several studies to reduce the formation of polyps by 30% to 50%. The effect is likely to occur with higher doses of aspirin (more than the 81-325 mg that is recommended for cardiovascular disease prevention), and there is concern about aspirin's side effect of gastrointestinal bleeding at these doses.

    Celecoxib (Celebrex), a "COX-2 selective NSAID" has been shown to reduce colon polyps 30% to 50% as well, but there is a lingering concern about the possible cardiovascular side effects that may be seen with most NSAIDs (though the data supporting this side effect is conflicting). It may be used in patients genetic polyposis syndromes who choose not to have their colons removed. Celecoxib might be considered in patients with a low risk for cardiovascular disease who develop adenomatous polyps frequently.

    Sulindac (Clinoril), a "non-selective NSAID" has been shown to prevent polyps in patients with sporadic adenoma as well as the genetic syndromes. As with celecoxib, there is concern about cardiovascular side effects.

    Given the information that is available, it is not recommended that patients at average risk for the formation of additional polyps be treated for prevention because of concern that the risks of treatment, primarily intestinal bleeding and cardiovascular disease, may outweigh the benefit of polyp prevention. It may be reasonable to treat patients who are at higher than average risk for polyps in whom the benefit may outweigh the risks. Such patients might include those with frequent polyp formation, particularly those who have demonstrated cancerous changes in the polyps, or patients who already have had colon cancer. Studies in these types of patients are eagerly awaited.

    How common are colon polyps?

    Colon polyps are very common. They increase in prevalence as people age; by age 60, one-third or more people will have at least one polyp. If a person has a colon polyp, he or she is more likely to have additional polyps elsewhere in the colon and is more likely to form new polyps at a later time. In a small subset of patients with colon polyps, there is a familial, genetic abnormality that causes them and other members of their families to develop larger numbers of polyps, to develop them at an early age, and to more frequently have them become cancerous (malignant).

    Why are colon polyps important?

    Colon polyps are important because they may give rise to colon cancer. Depending on the type of polyp, they predict who is more likely to develop further polyps and colon cancer. Polyps cause other problems (to be discussed), but it is the deadly nature of colon cancer that is of most concern.

    Benign polyps become malignant polyps (cancer) with further mutations and changes in the cells' genetic material (genes). The cells begin to divide and reproduce uncontrollably, sometimes giving rise to a larger polyp. Initially, the increasingly, genetically abnormal cells are limited to the layer of cells that line the inside of the colon. The cells then then develop the ability to invade deeper into the wall of the colon. Individual cells also develop the ability to break off from the polyp and spread into lymph channels through the wall of the colon to the local lymph nodes and then throughout the body, a process referred to as metastasis.

    The transition from benign to malignant polyp can be seen under the microscope. In the earlier phase of the transition, called low-grade dysplasia (dysplasia=abnormal formation), the cells and their relationships to one another become abnormal. When the cells and their relationships become even more abnormal, it is termed high-grade dysplasia. High-grade dysplasia is of greater concern because the cells are clearly cancerous although they are limited to the innermost lining of the colon; with rare exceptions, they have not yet developed the abilities to invade and metastasize. If they are not removed, invasion and metastasis may occur.

    Are all colon polyps the same?

    No, all polyps are not the same. There are different histologic types, that is, the cells that make up the polyp have different characteristics when viewed under the microscope. They also vary in size, number, and location. Most importantly, they vary in their tendency to become cancerous (malignant).

    Adenomatous polyps

    The most common type of polyp is the adenoma or adenomatous polyp. It is an important type of polyp not only because it is the most common, but because it is the most common cause of colon cancer. The likelihood that an adenoma will develop into (or has already developed into) cancer is partially dependent on its size; the larger the polyp, the more likely it is that the polyp is or will become malignant. Concern about the malignant potential increases with a polyp the size greater than one centimeter. It also matters if there is a single polyp or multiple polyps. Patients with multiple polyps - even if they are not malignant when examined under the microscope--are more likely to develop additional polyps in the future that may become malignant. Concern about this increasing malignant potential begins when there are three or more polyps. Finally, the malignant potential of an adenomatous polyp is related to the manner in which the cells of the polyp organize themselves as seen under the microscope. Cells that organize themselves into tubular structures (tubular adenomas) are less likely to become cancerous than cells that organize themselves into finger-like structures (villous adenomas).

    Most adenomatous polyps are considered sporadic, that is, they do not stem from a recognized genetic mutation that is present at birth. Nevertheless, the risk of having colon polyps greater than one centimeter in size or developing colon cancer is two-fold greater if a first degree relative has colon polyps greater than one centimeter in size. Therefore, there it is likely to be a genetic factor working even in sporadic adenomatous polyps.

    Genetic adenomatous polyp syndromes

    There are several familial, genetic conditions in which the mutations or the development of mutations are programmed into an individual's genes from before birth, passed down from parent to child. In the most common of these conditions, hundreds to thousands of adenomatous polyps form (familial adenomatous polyposis or FAP) as a result of a mutation in the APC gene. It is important to recognize these polyposis syndromes and the exact genetic abnormality that causes them, if possible since the malignant potential of these polyps is much greater than that of individuals without the genetic abnormality. (Eighty percent or more of these patients develop colon cancer.) Even though these syndromes are responsible for only a few percent of all colon cancers, recognition of a polyposis syndrome identifies patients in whom screening for additional polyps needs to be done more frequently so that new polyps and cancers can be discovered and treated early. It may even be recommended that the entire colon be removed to prevent cancer. In addition, genetic testing can be done for relatives of the patient with polyps to determine whether or not the relative has the same mutation as the patient and, therefore, is very likely to develop polyps and cancer. Relatives with the same mutation then can be screened for the presence of polyps and cancer, preferably starting at an earlier age than would normally be done because cancers in these syndromes develop at an earlier age than cancers not associated with a syndrome. Because of the autosomal dominant mode of transmission of the gene and its effects, only one parent needs to have the FAP gene to pass on to his or her children, and there is a 50/50 chance that each of his or her children will have FAP.

    There is an uncommon form of FAP in which the number of polyps is less than classic FAP - less than 100--called attenuated FAP. The mutation in the APC gene in attenuated FAP is different than the mutation in classic FAP. Patients with many polyps but not the numbers seen in FAP should be identified and tested for the mutation. Unlike FAP which is an autosomal dominant syndrome, attenuated FAP is a recessive mutation so that an individual needs to inherit one mutated gene from each parent to develop polyps and colon cancer, and because of the rarity of the mutation, this occurs rarely.

    Another syndrome of polyps and colon cancer is the MYH polyposis syndrome. Individuals with MYH polyposis develop less than 100 polyps at a young age and are at high risk for developing colon cancer. It is caused by mutations in a different gene than FAP, the MYH gene; however, the mutation occurs sporadically due to spontaneous mutations and, therefore, a hereditary pattern is not apparent in parents, but may be seen in siblings. Because it is an autosomal recessive gene that requires a mutated gene from each parent, the MYH polyposis syndrome is rare.

    Genetic adenomatous polyp syndromes

    The second most common type of colon polyp is the hyperplastic polyp. It is important to recognize these polyps and to differentiate them from adenomatous polyps since they have little or no potential to become cancerous unless they are located in the proximal (ascending colon), or show a particular histologic pattern under the microscope (a serrated appearance). Nevertheless, there are uncommon genetic syndromes in which patients form many hyperplastic polyps. These patients may be at a similar risk for developing colon cancer as patients with multiple adenomatous polyps, particularly if the polyps are large, serrated, located in the ascending colon, and there is a family history of colon cancer. Hyperplastic polyps may coexist with adenomatous polyps.

    Other types of colon polyps

    Much less common types of colon polyps exist, and their potential for becoming cancerous varies greatly, for example, hamartomatous, juvenile, and inflammatory polyps.

    What are the symptoms and signs of colon polyps?

    Ninety-five percent of colon polyps do not cause any symptoms or signs. The most common symptoms or signs when they do occur are those of bleeding from the polyp. This usually results in small amounts of blood in the stool, enough to turn stool tests for occult (hidden) blood abnormal, but not enough to change the color of stool. Occasionally when bleeding is substantial, the stool may become black, maroon or bright red.

    More commonly, however, the bleeding continues at a slow pace and can result in anemia due to a loss and subsequent deficiency of iron. If this happens, symptoms of anemia - weakness, light-headedness or fainting especially upon standing, pale skin, rapid heart rate, and occasionally congestive heart failure, stroke, or heart attack - may occur.

    (The reason that colon cancer screening often involves stool tests for occult blood is that colon polyps have a tendency to bleed; screening for blood in the stool identifies patients with a higher likelihood of having colon polyps who need colonoscopy to look for and remove the polyps.)

    How are colon polyps diagnosed?

    There are several means to diagnose colon polyps.

    Endoscopic colonoscopy

    Endoscopic colonoscopy involves the use of a colonoscope, a flexible tube approximately five feet in length with a light and camera at the end and a hollow channel through which instruments can be passed. The colonoscope is passed via the anus into the colon and then through the colon until the proximal end of the colon - the cecum - is reached. On withdrawal of the colonoscope, the lining of the colon is observed for polyps and other abnormalities. These may be biopsied or removed using electro-cautery and then examined under the microscope. Colonoscopy identifies 95% of polyps, small and large, though occasionally polyps are missed if they are small, hidden by folds in the colon's lining, or the colonoscopy is hurried.

    Virtual colonoscopy

    Virtual colonoscopy involves the use of either computerized tomography (CT) or magnetic resonance imaging (MRI). The colon is filled with either a liquid contrast agent or air, and CT or MRI is performed. Computerized reconstruction of either the CT or MRI images provides a virtual image that mimics the view obtained by a colonoscope. Virtual colonoscopy is very good at finding polyps but not as good as colonoscopy; it can miss polyps less than one centimeter in size, although the need to identify these smaller polyps is debated since they infrequently are malignant. MRI has an advantage over CT because of it does not expose the patient to radiation. It is more expensive, however, and there is less experience with MRI than with CT. The problem with both CT and MRI virtual colonoscopy is that if a polyp is found that should be removed, colonoscopy then must be done at a later time to remove it.

    Barium enema

    Barium enema is an older method of diagnosing colon polyps. During a barium enema, the colon is filled with barium, and multiple X-rays of the colon are taken as the patient changes position. Barium enema is a good way to diagnose polyps and is relatively inexpensive; however, it can easily miss small polyps and exposes patients to radiation. Moreover, the skills and experience necessary to do a barium enema properly have declined among radiologists because barium enemas are less frequently ordered now that colonoscopy and virtual colonoscopy are available. Finally, like virtual colonoscopy, if polyps are found, a colonoscopy must be done to remove the polyp.

    Flexible sigmoidoscopy

    Flexible sigmoidoscopy uses a shortened version of a colonoscope, approximately three feet in length. It is able to examine only the distal third to one-half of the colon. Like the colonoscope, it can be used to identify, biopsy, and remove polyps without exposure to radiation. For screening purposes, since the sigmoidoscope cannot examine the entire colon, it usually is combined with either less frequent colonoscopy or frequent stool occult blood tests to identify polyps beyond its reach.

    How should patients with colon polyps be followed?

    Several expert groups have made recommendations for surveillance in individuals who have been found to have polyps on their initial examination, which usually is endoscopic colonoscopy but occasionally virtual colonoscopy or flexible sigmoidoscopy. The recommendations vary slightly from group to group but not in important ways. They all make recommendations on the basis of factors such as family history of polyps and colon cancer, the number of polyps that are found, the size of the polyps, and the polyps' histology. By using these factors, the interval between surveillance procedures can be tailored to the risk of developing further polyps and malignancy in the future - the higher the risk, the shorter the interval between surveillance procedures. The recommendations that follow are modified from the guidelines proposed by the U.S. Multi-Society Task Force on Colorectal Cancer published in 2012.

    Second examination
    • If no polyps are found on the first examination it is recommended that a second examination should be done 10 years later.
    • If the only polyps that are found are hyperplastic polyps, and they are limited to the rectum and sigmoid colon and they are all less than one centimeter in size, a second examination is recommended in 10 years.
    • If one or two tubular adenomas are found and they are less than one centimeter in size, a second examination is recommended in five years though a longer interval may be reasonable as well.
    • If three to ten adenomas are found, it is recommended that a second examination be done in three years.
    • If more than ten adenomas are found, it is recommended that a second examination be done in three years or less.
    • If one or more tubular adenomas are found that are greater than one centimeter in size, a second examination is recommended in three years.
    • If one or more adenomas are found of any size and their histology is villous, a second examination is recommended in three years.
    • If one or more adenomas are found and any show high grade dysplasia, a second examination is recommended in three years.
    • If serrated polyps are found, recommendations are less secure because much less information is available about the future risk of polyps and cancers. Concerns are greater (and the interval to the next examination should be shorter) if the polyps are proximal (in the ascending colon), are larger (more than one centimeter in size), and particularly if they show dysplasia.
    Additional examinations

    Adenomas can be classified as low risk (LRA) and high risk (HRA) for cancer.

    LRA is defined as one to two tubular adenomas less than one centimeter in size.

    HRA is defined as three or more adenomas, with one tubular adenoma greater than one centimeter in size, or an adenoma with villous histology or high-grade dysplasia.

    Recommendations regarding when to have the third and subsequent examinations depend on the presence of LRA or HRA on the first and second examinations and can vary between three and 10 years.

    Are all colon cancers associated with polyps?

    No, although most colon cancers arise from polyps, some do not. Some arise within the wall of the colon. These cancers may be flat or even depressed (excavated). They are more difficult to identify and treat, and they are more likely to spread into the wall of the colon and nearby lymph nodes than cancers originating in polyps. This is particularly true of serrated adenomatous polyps which usually are flat rather than polypoid in appearance.

    There also is a familial, genetic syndrome called hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) in which colon cancers occur with very high incidence (80% or more of patients). There are few or no polyps to identify in these patients. Moreover, the cancers occur at a younger age, often prior to the time screening for colon cancer is recommended to begin, and the syndrome is not recognized until a family member develops cancer usually at a young age. HNPCC is suspected because other family members also have colon cancer and certain criteria are met (Amsterdam or Bethesda criteria), or the cancer shows a particular pattern under the microscope with special stains. If HNPCC is suspected, genetic testing on the cancer can be done to identify the hereditary mutation, and other family members can be tested for the same mutation. If present, the family members can begin screening colonoscopies. HNPCC may be associated with cancers in tissues outside the colon as well. Fortunately, HNPCC is responsible for only a few percent of all colon cancers.

    Can colon polyps be prevented?

    Because of concern regarding the transition of polyps to cancer, attempts have been made to determine if treatments with theoretical potential actually prevent polyps. The problem with most studies is that they are retrospective, observational studies which are not sufficient as proof. The long period of time (many years) that it takes for polyps to form makes long term studies mandatory, but such studies have been difficult to do except in the case of familial, genetic polyposis syndromes, and, because of the differences in their causes, it is not clear if what applies to them applies to the more common sporadic adenomas.

    Several associations have been explored for antioxidants including selenium, beta carotene, and vitamins A, C, and E. Most of the studies that have been done do not support a role for these agents in preventing polyps or in preventing colon cancer. A limited amount of support is available for the use of selenium to prevent polyps, but selenium is not recommended for use outside of experimental trials.

    Supplemental dietary calcium has been demonstrated in one study to prevent the formation of polyps. The benefit was seen with supplementation of 1200 mg of calcium. There is some concern about using calcium since higher dietary and supplemental levels are associated with an increase in vascular disease. The intake of calcium that was studied was higher than the recommended intake of calcium, 800 mg.

    The best support for a treatment to prevent polyps is with nonsteroidal anti-inflammatory drugs (NSAIDs), a class of drugs that includes aspirin, ibuprofen (Motrin, Advil), celecoxib (Celebrex), and many others. Aspirin has been shown in several studies to reduce the formation of polyps by 30% to 50%. The effect is likely to occur with higher doses of aspirin (more than the 81-325 mg that is recommended for cardiovascular disease prevention), and there is concern about aspirin's side effect of gastrointestinal bleeding at these doses.

    Celecoxib (Celebrex), a "COX-2 selective NSAID" has been shown to reduce colon polyps 30% to 50% as well, but there is a lingering concern about the possible cardiovascular side effects that may be seen with most NSAIDs (though the data supporting this side effect is conflicting). It may be used in patients genetic polyposis syndromes who choose not to have their colons removed. Celecoxib might be considered in patients with a low risk for cardiovascular disease who develop adenomatous polyps frequently.

    Sulindac (Clinoril), a "non-selective NSAID" has been shown to prevent polyps in patients with sporadic adenoma as well as the genetic syndromes. As with celecoxib, there is concern about cardiovascular side effects.

    Given the information that is available, it is not recommended that patients at average risk for the formation of additional polyps be treated for prevention because of concern that the risks of treatment, primarily intestinal bleeding and cardiovascular disease, may outweigh the benefit of polyp prevention. It may be reasonable to treat patients who are at higher than average risk for polyps in whom the benefit may outweigh the risks. Such patients might include those with frequent polyp formation, particularly those who have demonstrated cancerous changes in the polyps, or patients who already have had colon cancer. Studies in these types of patients are eagerly awaited.

    Source: http://www.rxlist.com

    Ninety-five percent of colon polyps do not cause any symptoms or signs. The most common symptoms or signs when they do occur are those of bleeding from the polyp. This usually results in small amounts of blood in the stool, enough to turn stool tests for occult (hidden) blood abnormal, but not enough to change the color of stool. Occasionally when bleeding is substantial, the stool may become black, maroon or bright red.

    More commonly, however, the bleeding continues at a slow pace and can result in anemia due to a loss and subsequent deficiency of iron. If this happens, symptoms of anemia - weakness, light-headedness or fainting especially upon standing, pale skin, rapid heart rate, and occasionally congestive heart failure, stroke, or heart attack - may occur.

    (The reason that colon cancer screening often involves stool tests for occult blood is that colon polyps have a tendency to bleed; screening for blood in the stool identifies patients with a higher likelihood of having colon polyps who need colonoscopy to look for and remove the polyps.)

    Source: http://www.rxlist.com

    Health Services in

    Define Common Diseases

    Women's Health Care helps you find information, definitaions and treatement options for most common diseases, sicknesses, illnesses and medical conditions. Find what diseases you have quick and now.